MGMA’s position stems from concerns over vendor readiness to provide upgrades and support in time to help practices avoid penalties in 2015. The letter states: “Even if a vendor does upgrade their product to meet the Stage 2 criteria and successfully certifies this product late in 2013 or sometime in 2014, these products must still be deployed to the client practices and staff trained on the new software and new Stage 2 reporting requirements.”
To combat the issue, MGMA recommends HHS extend both the stage 2 and stage 1 reporting periods to help practices avoid penalties, conduct a comprehensive vendor survey to assess readiness and build additional flexibility into the stage 2 reporting requirements.
MGMA has 22,500 members representing 280,000 physicians nationwide.
More Articles on Meaningful Use:
CMS to Host Webinar on Meaningful Use Stage 2
HIMSS: Launch MU2 on Time, But Increase Attestation Period
ONC Workgroup Releases Meaningful Use Stage 3 Recommendations
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
